Finanzdaten der Angiodynamic Inc-Aktie (ANGO)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-08-31 | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 6.57%80.92 | 86.61 | 78.42 | 79.43 | 75.71 |
| Cost Of Revenue | 17.47%32.88 | 39.83 | 36.94 | 34.65 | 33.85 |
| Gross Profit | 2.71%48.04 | 46.77 | 41.48 | 44.78 | 41.86 |
2.85%55.34 | 56.97 | 54.43 | 50.91 | 52.51 | |
| Research and Development | 2.43%7.98 | 8.18 | 7.08 | 7.77 | 6.42 |
| Depreciation and Amortization | 1.77%5.50 | 5.60 | 5.59 | 5.75 | 6.02 |
| Operating Income/Loss | 28.38%-7.30 | -10.20 | -12.95 | -6.13 | -10.66 |
| Nonoperating Income/Loss | 0.01 | - | 4.88 | -0.23 | -0.18 |
| Income/Loss From Continuing Operations Before Tax | 33.88%-7.30 | -11.04 | -8.07 | -6.36 | -10.84 |
| Income Tax Expense/Benefit, Deferred | 304.00%-0.31 | 0.15 | 0.06 | -0.05 | -0.02 |
| Income Tax Expense/Benefit | 153.78%-0.20 | 0.37 | 0.01 | -0.01 | 0.07 |
37.77%-7.10 | -11.41 | -8.08 | -6.35 | -10.90 | |
| Attributable To Parent | 37.77%-7.10 | -11.41 | -8.08 | -6.35 | -10.90 |
| Basic Average Shares | 42.02 | - | 41.60 | 41.54 | 41.17 |
| Diluted Average Shares | 42.02 | - | 41.60 | 41.54 | 41.17 |
| Basic Earnings Per Share | -0.17 | - | -0.19 | -0.15 | -0.26 |
| Diluted Earnings Per Share | -0.17 | - | -0.19 | -0.15 | -0.26 |